Recent research has shown that certain forms of E. coli bacteria tend to colonize hypoxic areas of the body, including tumors, suggesting they might be playing a role in cancer therapeutics.

I have been a physician for over forty years with an office practice and providing geriatric house calls in our community.

A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

October is Breast Cancer Awareness Month, and the experts at City of Hope Orange County will be donning pink coats in support ...

Updated clinical results to be presented from the ongoing Phase 1/2 ABILITY-1 study of MDNA11 in advanced or metastatic solid tumorsPreclinical ...

A new report from the American Cancer Society says deaths from the disease have fallen nearly 45% compared to 35 years ago. However, new cases continue to rise.

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, today announced two ...

For Breast Cancer Awareness Month, Oranus Mohammadi, MD, discussed the remarkable progress made in improving survival rates ...

FDA approves Bristol Myers' Opdivo for resectable non-small cell lung cancer, reducing recurrence risk by 42% and showing 70% 18-month event-free survival in patients.

Rose-Anna Hoey never imagined that she would be given a cancer diagnosis, as a leading distance runner with no genetic ...

The University of Arizona Cancer Center has long been at the forefront of breast cancer research and treatment. Lately, the ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...